Kim Eun Soo, Jeon Seong Woo, Park Soo Young, Cho Chang Min, Tak Won Young, Kweon Young Oh, Kim Sung Kook, Choi Yong Hwan
Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
J Gastroenterol Hepatol. 2009 Jan;24(1):114-9. doi: 10.1111/j.1440-1746.2008.05674.x. Epub 2008 Dec 1.
Covered metal stents have been accepted as the treatment of choice for malignant dysphagia caused by esophageal and gastric cardia cancer, but stent migration is a major shortcoming. A double-layered Niti-S stent was therefore introduced to obviate this problem. We aimed to compare double-layered and covered Niti-S stents regarding safety, efficacy, and feasibility in the treatment of malignant dysphagia.
Thirty-seven consecutive patients with malignant dysphagia due to inoperable esophageal or gastric cardia cancer were enrolled in a prospective, randomized study. The main outcomes were technical success, improvement in dysphagia score after stent insertion, and complications.
Technical success was achieved at a similar rate in both groups (covered, 19/19 [100%]vs double layered, 16/17 [94%]). A week after stent insertion, the mean dysphagia score improved significantly in the covered and double-layered groups compared to baseline (from 2.95 +/- 0.52 and 2.88 +/- 0.33 to 1.00 +/- 0.47 and 1.06 +/- 0.24, respectively; P < 0.001). There was no difference in the survival of the patients in the two groups. The overall complications, including stent migration and tumor overgrowth, occurred more frequently with covered stents (11/19 [58%]) than double-layered stents (2/17 [12%]; P = 0.006).
Newly-developed, self-expanding metal stents, (covered and double-layered Niti-S stents) were equally effective and feasible treatments for malignant dysphagia. However, double-layered Niti-S stents are preferable due to their favorable safety profile.
覆膜金属支架已被公认为治疗食管癌和贲门癌所致恶性吞咽困难的首选方法,但支架移位是一个主要缺点。因此,引入了双层镍钛合金支架来解决这个问题。我们旨在比较双层和覆膜镍钛合金支架在治疗恶性吞咽困难方面的安全性、有效性和可行性。
37例因无法手术的食管癌或贲门癌导致恶性吞咽困难的连续患者纳入一项前瞻性随机研究。主要结局指标为技术成功率、支架置入后吞咽困难评分的改善情况及并发症。
两组的技术成功率相似(覆膜组,19/19[100%];双层组,16/17[94%])。支架置入一周后,覆膜组和双层组的平均吞咽困难评分与基线相比均显著改善(分别从2.95±0.52和2.88±0.33降至1.00±0.47和1.06±0.24;P<0.001)。两组患者的生存率无差异。包括支架移位和肿瘤过度生长在内的总体并发症在覆膜支架组(11/19[58%])比双层支架组(2/17[12%])更常见(P=0.006)。
新开发的自膨式金属支架(覆膜和双层镍钛合金支架)在治疗恶性吞咽困难方面同样有效且可行。然而,双层镍钛合金支架因其良好的安全性更具优势。